Allegretti et al.
2019
Safety and effectiveness of bexagliflozin in patients with type 2 diabetes mellitus and stage 3a/3b CKD
DE1314960U
(enExample )
Lin et al.
2025
Effect of antibacterial agents on dentin bonding system: A systematic review and meta-analysis
Chicaíza-Becerra et al.
2012
Cost-effectiveness of iso-versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy
FI3870233T3
(fi )
2024-02-07
Paklitakseli-Hyaluronihapon konjugaatti käytettäväksi ei-lihasinvasiivisen virtsarakon syövän hoidossa
JPWO2020013265A5
(enExample )
2022-07-06
You et al.
2006
Helicobacter pylori eradication prior to initiation of long-term non-steroidal anti-inflammatory drug therapy in Chinese patients-a cost-effectiveness analysis.
DE1368111U
(enExample )
AU2022219031A1
(en )
2023-09-07
Agents, compositions, and methods for the treatment of hypoxia and ischemia-related disorders
DE1291619U
(enExample )
DE1348562U
(enExample )
DE1470619U
(enExample )
DE1289921U
(enExample )
FI4132587T3
(fi )
2024-07-22
HA-paklitakselikonjugaatti mesoteliooman hoitoon
JP2009518406A5
(enExample )
2010-01-28
DE1362556U
(enExample )
DE1420250U
(enExample )
Sevastos
2009
Surviving calciphylaxis.
Desruisseaux
2016
Olmesartan-medoxomil
DE1437417U
(enExample )
Chicaiza-Becerra et al.
2012
PUBLICACIÓN ANTICIPADA EN LINEA
JPWO2020084525A5
(enExample )
2022-10-04
Pigon
1995
Aspects of the pathogenesis of low insulin response in man.
ŞAHİN et al.
2009
Effectiveness and Adverse Effects of the Implanon®
DE1302642U
(enExample )